Canine mast cell tumours (MCTs) represent one of the most prevalent neoplasms in dogs, characterised by their markedly heterogeneous clinical behaviour. These tumours, ranging from benign lesions ...

The randomized, double-blind, placebo controlled parallel group decentralized trial will enroll 60 patients with idiopathic Mast Cell Activation Syndrome (“MCAS”). Per the protocol ...

To participate, submit your response here by June 20 at 9 a.m. Eastern. This week’s winners will be announced by July 1. By The Learning Network Here are all of our Student Opinion questions ...